H R 3 (2019)
Summary:
Directs the federal government to negotiate drug prices for Medicare directly with pharmaceutical companies and caps out-of-pocket costs for Medicare part D enrollees.
Want hearing dates, vote records or the full bill text? See more on the Statehouse website
https://www.govtrack.us/congress/bills/116/hr3
Browse related articles and bills:
